Surgery Partners Stock Today

SGRY Stock  USD 32.89  0.84  2.49%   

Performance

1 of 100

 
Low
 
High
Weak

Odds Of Distress

Less than 40

 
100  
 
Zero
Below Average
Surgery Partners is trading at 32.89 as of the 22nd of February 2024; that is -2.49 percent decrease since the beginning of the trading day. The stock's open price was 33.73. Surgery Partners has about a 40 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Surgery Partners are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of January 2024 and ending today, the 22nd of February 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
1st of October 2015
Category
Healthcare
Classification
Health Care
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 126.49 M outstanding shares of which 7.78 M shares are at this time shorted by private and institutional investors with about 9.45 trading days to cover. More on Surgery Partners

Surgery Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Surgery Partners' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgery Partners or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, DirectorMichael Doyle
SEC FilingsSurgery Partners Security & Exchange Commission EDGAR Reports
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Surgery Partners report their recommendations after researching Surgery Partners' financial statements, talking to executives and customers, or listening in on Surgery Partners' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Surgery Partners. The Surgery consensus assessment is calculated by taking the average forecast from all of the analysts covering Surgery Partners.
Financial Strength
Based on the key indicators related to Surgery Partners' liquidity, profitability, solvency, and operating efficiency, Surgery Partners is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. Financial strength of Surgery Partners is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Shares Diluted85.2 M105.7 M
Significantly Down
Slightly volatile
Weighted Shares85.1 M105.7 M
Significantly Down
Slightly volatile
Return on Assets(0.0099)(0.0092)
Significantly Down
Slightly volatile
Net Cash Flow from Operations163.5 M182.6 M
Moderately Down
Slightly volatile
Current Liabilities484.3 M567.4 M
Fairly Down
Slightly volatile
Total Liabilities3.9 B4.3 B
Significantly Down
Slightly volatile
Gross Margin0.220.2
Significantly Up
Slightly volatile
Total DebtB3.3 B
Moderately Down
Slightly volatile
Asset Turnover0.350.35
Steady
Very volatile
Current Assets866.6 M1.1 B
Significantly Down
Slightly volatile
Total Assets6.3 B7.7 B
Significantly Down
Slightly volatile
Surgery Partners' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Surgery Partners' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Surgery Partners' financial leverage. It provides some insight into what part of Surgery Partners' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Surgery Partners' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Surgery Partners deploys its capital and how much of that capital is borrowed.
Liquidity
Surgery Partners cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.93 B in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Surgery Partners has a current ratio of 1.48, which is within standard range for the sector. Debt can assist Surgery Partners until it has trouble settling it off, either with new capital or with free cash flow. So, Surgery Partners' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Surgery Partners sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Surgery to invest in growth at high rates of return. When we think about Surgery Partners' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

163.51 Million
Surgery Partners (SGRY) is traded on NASDAQ Exchange in USA. It is located in 340 Seven Springs Way, Brentwood, TN, United States, 37027 and employs 9,100 people. Surgery Partners is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgery Partners's market, we take the total number of its shares issued and multiply it by Surgery Partners's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Surgery Partners conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 126.49 M outstanding shares of which 7.78 M shares are at this time shorted by private and institutional investors with about 9.45 trading days to cover. Surgery Partners currently holds about 227.4 M in cash with 238.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.58.
Check Surgery Partners Probability Of Bankruptcy
Ownership Allocation
Surgery Partners maintains a total of 126.49 Million outstanding shares. The majority of Surgery Partners outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Surgery Partners to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Surgery Partners. Please pay attention to any change in the institutional holdings of Surgery Partners as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Surgery Ownership Details

Surgery Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Surgery Partners jumping above the current price in 90 days from now is about 36.83%. The Surgery Partners probability density function shows the probability of Surgery Partners stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 3.2219. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Surgery Partners will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Surgery Partners is significantly underperforming NYSE Composite.
  Odds Below 32.89HorizonTargetOdds Above 32.89
62.85%90 days
 32.89 
36.83%
Based on a normal probability distribution, the odds of Surgery Partners to move above the current price in 90 days from now is about 36.83 (This Surgery Partners probability density function shows the probability of Surgery Stock to fall within a particular range of prices over 90 days) .

Surgery Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Surgery Partners that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Surgery Partners' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Surgery Partners' value.
InstituionRecorded OnShares
Geode Capital Management, Llc2023-09-30
1.4 M
Avidity Partners Management Lp2023-09-30
1.3 M
Goldman Sachs Group Inc2023-09-30
1.2 M
T. Rowe Price Associates, Inc.2023-12-31
1.1 M
Iron Triangle Partners Lp2023-12-31
M
Norges Bank2023-12-31
805.4 K
Northern Trust Corp2023-09-30
684.2 K
Victory Capital Management Inc.2023-12-31
565 K
Charles Schwab Investment Management Inc2023-09-30
539.5 K
Bain Capital Investors Llc2023-09-30
58.2 M
Fmr Inc2023-09-30
19 M
View Surgery Partners Diagnostics

Surgery Partners Historical Income Statement

Surgery Partners Income Statement is one of the three primary financial statements used for reporting Surgery's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Surgery Partners revenue and expense. Surgery Partners Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Surgery Partners' Direct Expenses is fairly stable as compared to the past year. Consolidated Income is likely to rise to about 107.9 M in 2024, whereas Cost of Revenue is likely to drop slightly above 1.8 B in 2024. View More Fundamentals

Surgery Stock Against Markets

Picking the right benchmark for Surgery Partners stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Surgery Partners stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Surgery Partners is critical whether you are bullish or bearish towards Surgery Partners at a given time. Please also check how Surgery Partners' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Surgery Partners without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Surgery Partners Corporate Directors

Surgery Partners corporate directors refer to members of a Surgery Partners board of directors. The board of directors generally takes responsibility for the Surgery Partners' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Surgery Partners' board members must vote for the resolution. The Surgery Partners board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.

How to buy Surgery Stock?

Before investing in Surgery Partners, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Surgery Partners. To buy Surgery Partners stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Surgery Partners. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Surgery Partners stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Surgery Partners stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Surgery Partners stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Surgery Partners, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Already Invested in Surgery Partners?

The danger of trading Surgery Partners is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Surgery Partners is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Surgery Partners. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Surgery Partners is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Surgery Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surgery Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgery Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgery Partners Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgery Partners. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Surgery Stock analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Revenue Per Share
22.688
Quarterly Revenue Growth
0.086
Return On Assets
0.0372
Return On Equity
0.0388
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.